1. Introduction {#s0005}
===============

The 40-Hz auditory steady-state response (ASSR) measures the ability of a neural population to entrain to repeating auditory stimulation at gamma-band frequency ([@bb0300]). Gamma-band oscillations help establish temporal precision in local cortical networks ([@bb0390]), and are candidate mechanisms of perceptual integration, attentional selection, and working memory ([@bb0320]; [@bb0370]). Abnormal gamma oscillations are critical elements of current disease models of schizophrenia (SZ), including the *N*-methyl-[d]{.smallcaps}-aspartate receptor (NMDAR) hypofunction and GABAergic dysfunction models ([@bb0340]). Gamma oscillation generation is thought to depend on the integrity of neural circuits involving fast-spiking parvalbumin (PV)-expressing cells and NMDAR activation on interneurons, whose alteration is suspected to underlie psychosis ([@bb0175]; [@bb0240]). Specifically, the network of GABAergic interneurons and the negative feedback interaction between pyramidal cells and fast-spiking PV interneurons are hypothesized to be a key circuitry responsible for gamma band oscillations ([@bb0390]). As can be seen, gamma oscillation mechanisms have been relatively well-articulated in animal model studies ([@bb0040]), and the 40-Hz ASSR has been represented as promising targets in translational research ([@bb0260]).

Previous studies on the 40-Hz ASSR have reported reductions in the evoked power and phase-locking measures (i.e., inter-trial phase coherence (ITC)) in patients with SZ ([@bb0385]), though the results are not entirely consistent. For instance, Hong et al. ([@bb0155]) demonstrated enhanced evoked power in patients with SZ taking atypical antipsychotics. Hamm et al. ([@bb0125]) also reported higher phase-locking measures in patients with SZ compared to HCs. The authors employed novel stimulus parameters, including broadband auditory noise and a wide inter-stimulus interval (ISI). A recent new line of research investigating spontaneous (non-phase locked) gamma-band activity levels found enhanced gamma activity, both during the ASSR stimulus presentation and the task baseline ([@bb0150]). These findings may correspond with animal studies reporting an association between NMDAR hypofunction and increased spontaneous gamma power ([@bb0070]; [@bb0215]), and together indicate the need to investigate the mechanisms and clinical implications of different ASSR measures.

Only a few studies have explicitly distinguished the ASSR measures. Mathalon and Sohal ([@bb0255]) classified the ASSR measures into stimulus-evoked oscillations (evoked power), stimulus-induced oscillations (total power), and stimulus-independent oscillations (baseline or resting-state power). Evoked power reflects bottom-up sensory encoding, while spontaneous gamma power (stimulus-induced and stimulus-independent oscillations) is related to emerging dynamic processes in cortical networks ([@bb0165]). In addition to distinct ASSR measures, experimental parameters and sample characteristics may have contributed to the previous discrepant results. For example, studies differed in their ISI and sex ratio ([@bb0125]; [@bb0155]), and other factors including handedness and attentional manipulation could have influenced the results ([@bb0105]; [@bb0265]).

While the relationship between brain anatomical alterations and the 40-Hz ASSR deficits may provide a potential explanation for the pathophysiology of SZ, there are limited studies on this topic. Previous studies have localized the generator of the 40-Hz ASSR in the primary auditory cortex in the superior temporal gyrus (STG) and in subcortical and cerebellar regions ([@bb0120]; [@bb0145]). There is evidence for anatomical alterations of pyramidal cells in the primary auditory cortex of SZ ([@bb0055]; [@bb0360]), and the 40-Hz ASSR could be associated with gray matter loss and symptom severity in SZ ([@bb0115]). To date, only one study has examined the relationship between the 40-Hz ASSR and the thickness of the STG in SZ ([@bb0060]). This study found a positive correlation between the 40-Hz ASSR and left STG thickness in a healthy population but not in patients with SZ. More studies need to investigate the association between 40-Hz ASSR deficits and brain anatomy in SZ, especially with potentially different measures of the 40-Hz ASSR and a sample consisted of different demographic composition (e.g., ratios of included men and women and diverse cultural backgrounds).

In this study, we aimed to examine how different measures of the 40-Hz ASSR ([@bb0255]) are altered in SZ. We also sought to investigate the link between the 40-Hz ASSR functions and brain structural abnormalities in SZ. This was done by examining the correlation between the sensor and source level 40-Hz ASSR activities and gray matter volume alterations in the STG. Finally, to further understand the clinical and functional significance of the 40-Hz ASSR, we examined whether the 40-Hz ASSR is associated with cognitive and social functioning in SZ.

2. Material and methods {#s0010}
=======================

2.1. Participants {#s0015}
-----------------

A total of 33 patients with SZ (male: 16, female: 17, age: 42.21 ± 10.99 (range: 21--60)) were recruited and assessed for Axis I ([@bb0075]) and II ([@bb0080]) disorders, based on the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (SCID). Their psychiatric symptoms were evaluated using the Positive and Negative Syndrome Scale (PANSS) ([@bb0180]). No patient had a lifetime history of central nervous system disease, alcohol or drug abuse, mental retardation, or head injury with loss of consciousness, and no patient had current Axis II disorders. All patients were receiving atypical antipsychotic medication at the time of testing.

A total of 30 healthy controls (HCs) (male: 13, female: 17, age: 43.33 ± 12.95 (range: 23--64)) were recruited from the local community through newspapers and flyers. An initial screening interview excluded subjects with any identifiable neurological disorder, head injury, or any personal or family history of psychiatric illness. After the initial screening, potential HCs were interviewed using the SCID for Axis II Psychiatric Disorders ([@bb0080]) and were excluded if they had any of these disorders. All subjects signed a written informed consent form approved by the Institutional Review Board of Inje University Ilsan Paik Hospital, Republic of Korea (2015-07-23).

2.2. Psychological measures {#s0020}
---------------------------

Psychological measures and scales were used to measure neurocognition and functional outcome. To evaluate neurocognition, the Trail Making Test-A & ---B (TMT-A & TMT---B) ([@bb0335]), verbal fluency test ([@bb0245]), and Korean-Auditory Verbal Learning Test (K-AVLT) ([@bb0190]) were applied. In the TMT-A, participants were asked to draw lines sequentially connecting 25 consecutive, encircled numbers distributed across a sheet of paper within 360 s. In the TMT-B, participants were instructed to draw lines alternating between numbers and Korean letters within 300 s ([@bb0335]). The TMT-A and TMT-B, which were scored according to the time taken to complete the task, mainly evaluated visual attention and executive functioning, respectively. Longer time scores indicated worse performance. In the verbal fluency test, the participants named as many animals as possible within 60 s. This task evaluates verbal production and semantic memory abilities ([@bb0245]). The Korean-Auditory Verbal Learning Test (K-AVLT), which is included in the Rey-Kim Memory Test ([@bb0190]), is a verbal memory test that consists of five immediate recall trials (trials 1--5), plus delayed recall and delayed recognition trials. The immediate recall score is the sum of words (trials 1--5) recalled correctly. The delayed recall score indicates the number of words recalled correctly after a delay period of 20 min. The delayed recognition score indicates the correctly chosen words in the original list (15 words) spoken by the examiner among a list of 50 words after delayed recall.

To assess functional outcome, the Social Functioning Questionnaire (SFQ) ([@bb0195]; [@bb0425]) and Social and Occupational Functioning Assessment Scale (SOFAS) ([@bb0090]; [@bb0235]) were applied. The SFQ ([@bb0425]) is a 16-item self-report instrument, which assesses both frequency (eight items) and satisfaction (eight items) with various social behaviors enacted during the 2 weeks preceding the assessment. This measure yields the following separate indices of social functioning: frequency, satisfaction, and global. Higher scores indicate worse social functioning. The SOFAS was used as a one-item rating scale for Axis V (i.e. the clinician\'s judgment of overall level of functioning) in the Diagnostic and Statistical Manual for Mental Disorders, 4th Edition. The SOFAS is a global rating of current functioning, ranging from 0 to 100, with lower scores representing lower functioning ([@bb0090]; [@bb0235]).

2.3. Auditory stimuli and procedures {#s0025}
------------------------------------

Participants were seated in a comfortable chair in a quiet, shielded room in front of a computer screen (Mitsubishi, 22-in. CRT monitor). They were instructed to look at the fixation cross on the monitor with their eyes open while listening to auditory stimuli. The auditory stimuli were presented binaurally through MDR-D777 headphones (Sony, Tokyo, Japan). The auditory stimuli were click sounds (80 dB, 1 ms) that were presented in 500-ms trains at 40-Hz. Click sound trains were presented in a single block containing 150 trains. The inter-train interval was randomized between 3050 and 3500 ms. The experiment required approximately 10 min to complete. The stimuli were generated by *E*-Prime software (Psychology Software Tools, Pittsburgh, PA, USA).

2.4. Electroencephalography recording and preprocessing {#s0030}
-------------------------------------------------------

The electroencephalography (EEG) recording was synchronized to stimulus presentation onset by E-Prime. EEG was recorded using a NeuroScan SynAmps amplifier (Compumedics USA, Charlotte, NC, USA), with 64 Ag-AgCl electrodes mounted on a Quik-Cap, using an extended 10--20 placement scheme. The ground electrode was placed on the forehead and the physically linked reference electrode was attached to both mastoids. The vertical electrooculogram (EOG) channels were positioned above and below the left eye, while the horizontal EOG channels were recorded at the outer canthus of each eye. The impedance was maintained below 5 kΩ. All data were recorded with a 0.1--100 Hz band pass filter and a 60 Hz notch filter, with a sampling rate of 1000 Hz.

The recorded EEG data were preprocessed using CURRY 7 (Compumedics USA, Charlotte, NC, USA). The EEG data were re-referenced to an average reference. Gross artifacts, such as movement artifacts, were rejected by visual inspection by a trained person who had no prior information regarding the data origin. Artifacts related to eye movement or eye blinks were removed using the mathematical procedure implemented in the preprocessing function ([@bb0330]) of the CURRY 7 software. Data were then epoched from the 300 ms pre-stimulus to the 1000 ms post-stimulus. The baseline correction was performed using the pre-stimulus period. The epochs were rejected if they contained significant physiological artifacts (amplitude exceeding ±75 μV) in any site over 62 electrodes. The number of epochs of ASSR used for the analysis did not significantly differ between patients with SZ and HCs (SZ: 116.03 ± 23.73; HC: 120.07 ± 27.20, *p* = .532).

### 2.4.1. Time-frequency analysis {#s0035}

To measure spectral power, an event-related spectral perturbation (ERSP) analysis was applied to the recorded EEG signals. ERSP was calculated using functions implemented in a well-known MATLAB toolbox EEGLAB (<http://sccn.ucsd.edu/eeglab/>) ([@bb0050]; [@bb0270]).

Spectral power was calculated using the short-time Fourier transform every 5 ms, with a Hanning window size of 250 ms for each trial. No smoothing or filtering process was applied to generate the resultant ERSP maps. The power spectrum of each trial was then normalized with respect to the average power of the baseline period (−300 to 0 ms) to probe for changes in the spectral power values before and after stimulus onset. The normalized power spectra were then averaged over trials, which resulted in baseline-normalized ERSP maps and total power for each individual. Evoked power was also calculated as the spectral power of the averaged single epochs using the short-time Fourier transform as above. Evoked power measures the power of the average evoked potential in which the contribution of non-stimulus locked activity is minimized. Furthermore, spectral power was computed during the baseline period (baseline power). The short-time Fourier transform was applied to the single trial epochs, and the single trial power spectra were averaged for the baseline power spectrum. Power values, including total, evoked, and baseline power, were 10 × log~10~ transformed ([@bb0185]).

In addition to spectral power, the inter-trial phase coherence (ITC) was calculated, which measures the similarity in the phase of oscillatory activity across individual trials, independent of the signal amplitude. The ITC was quantified by dividing the complex output of the ERSP by its complex norm (absolute value), which was then averaged across trials. The complex norm of this averaged value resulted in the ITC value for different time and frequency points. ITC values ranged from 0 (i.e., non-phase locked, random activity across trials) to 1 (i.e., activity that is fully locked in phase across individual trials at a given latency). We used the ERSP and ITC as measures of power and phase, respectively, since these parameters provided information about the temporal dynamics of ASSR.

The mean baseline power was calculated at the Cz electrode by averaging the data over the baseline period (−300 to 0 ms) for 36--45 Hz. The mean total and evoked power and mean ITC were calculated at the Cz electrode by averaging the data over the first 500 ms within a trial (0--500 ms) for 36--45 Hz ([@bb0220]; [@bb0375]). For the time-course analyses, we calculated the mean total and evoked power and mean ITC for each 100-ms epoch (i.e., 0--100, 100--200, 200--300, 300--400, and 400--500 ms) ([@bb0250]; [@bb0280]).

### 2.4.2. Source imaging {#s0040}

Standardized low-resolution brain electromagnetic tomography (sLORETA) was used to compute the cortical distribution of the standardized source current density of the 40-Hz ASSR. sLORETA is a representative source-imaging method for solving the EEG inverse problem ([@bb0285]), which assumes that the source activation of a voxel is similar to that of the surrounding voxels for calculating a particular solution and applies an appropriate standardization of current density. The lead field matrix was computed using a realistic head model segmented based on the Montreal Neurological Institute (MNI) 152 standard template, wherein the three-dimensional solution space was restricted only to the cortical gray matter and hippocampus ([@bb0085]). The solution space is composed of 6239 voxels with a 5-mm resolution. Anatomical labels, such as the Brodmann areas, were provided by using an appropriate transformation from MNI to Talairach space ([@bb0035]).

The source image of the ASSR was analyzed in the baseline period (−300--0 ms) and auditory-stimulus period (0--500 ms) for 36--45 Hz. Three types of source image for the ASSR were estimated. First, the source images of each trial in the auditory-stimulus period were calculated and averaged (i.e., total source activity). Second, the source image of each averaged single epoch was calculated (i.e., evoked source activity). Third, the source images of each trial in the baseline period were calculated and averaged (i.e., baseline source activity). The region of interest (ROI) of the ASSR source activities in this study was the STG, a region well known to be associated with the 40-Hz ASSR and interneuron deficits ([@bb0060]). The source measure for phase locking was not calculated, since it is not reasonable to use phase information of power obtained from sLORETA.

2.5. Magnetic resonance imaging acquisition and voxel-based morphometry {#s0045}
-----------------------------------------------------------------------

Magnetic resonance imaging (MRI) was performed using a 1.5 T scanner (Magneton Avanto, Siemens, Erlangen, Germany). Head motion was minimized by using restraining foam pads provided by the manufacturer. A high-resolution T1-weighted MRI volume dataset was acquired with the following; acquisition parameters of a 227 × 384 acquisition matrix, a 210 × 250 field-of-view, 0.9 × 0.7 × 1.2 voxel size, a total of 87,168 voxels, an echo time (TE) of 3.42 ms, a repetition time (TR) of 1900 ms, 1.2 mm slice thickness, and a flip angle of 15°.

The voxel-based volumetry (VBM) was conducted using Computational Anatomy Toolbox (CAT12; developed by Christian Gaser, University of Jena, <http://dbm.neuro.uni-jena.de/cat>) with the SPM12 software package (Wellcome Department of Cognitive Neurology, London, UK) ([@bb0020]; [@bb0025]). The structural T1 images were registered to an ICBM East Asian template and normalized using the DARTEL algorithm ([@bb0015]). The images were then segmented into gray matter, white matter, and cerebrospinal fluid ([@bb0030]). Jacobian transformed tissue probability maps were used to modulate images to obtain volume differences in gray matter. The volume of the regions was extracted using the Neuromorphometrics atlas, available in SPM 12, provided by Neuromorphometrics, Inc. (<http://neuromorphometrics.com>). The STG was analyzed as an ROI of brain volume.

2.6. Statistical analysis {#s0050}
-------------------------

For statistical analyses, independent t-tests were used to compare the demographic data, psychological measures, and mean baseline power at Cz between the patients with SZ and the HCs. A repeated-measures analysis of variance (ANOVA) was performed separately with 5 time-blocks (0--100, 100--200, 200--300, 300--400, and 400--500 ms) as the within-subjects factors, and the groups (i.e., SZ and HC) as the between-subjects factors for total and evoked power and ITC at Cz. Furthermore, a repeated-measures ANOVA was performed separately with hemisphere (left and right) as the within-subjects factors and the groups as the between-subjects factors for the source activities of the ASSR and the volume of the ROI. When volume was included in the analysis, the total intracranial volume (TIV) was considered as a covariate to correct for different brain sizes ([@bb0325]). When a significant effect was found, post-hoc comparisons were performed using an independent t-test or Bonferroni correction or a univariate ANOVA with TIV as a covariate.

The relationship between the 40-Hz ASSR sensor and source measures and STG volume was analyzed using hierarchical regression analyses with a 5000 bootstrap resampling technique to correct for multiple correlations. The bootstrap test is a weaker method than the Bonferroni test for solving the multiple comparison problem; however, the robustness and stability of the bootstrap test have been recognized by various previous studies ([@bb0130]; [@bb0295]; [@bb0315]). Further, the bootstrap test has been widely used in EEG analysis ([@bb0200]; [@bb0290]). Analogous analyses were computed for the 40-Hz ASSR sensor and source measures and the psychological measures. Differences with a *p* \< .05 (two-tailed) were deemed to be statistically significant. Statistical analyses were performed using SPSS 21 (SPSS, Inc., Chicago, IL, USA).

3. Results {#s0055}
==========

3.1. Demographic and psychological characteristics {#s0060}
--------------------------------------------------

[Table 1](#t0005){ref-type="table"} shows the demographic and psychological characteristics of the SZ and HC groups. The verbal fluency and K-AVLT-delayed recall scores were significantly higher in the HC compared with the SZ group (verbal fluency: 15.91 ± 4.84 vs. 19.00 ± 5.82, *p* = .027; K-AVLT-delayed recall: 6.31 ± 3.65 vs. 9.89 ± 2.08, *p* \< .001, respectively). No other significant differences were found.Table 1Demographic characteristics of patients with SZ and HCs.Table 1SZ (N = 33)HC (N = 30)*p*Age (years)42.21 ± 10.9943.33 ± 12.950.711Sex Male16 (48.5)13 (43.3)0.682 Female17 (51.5)17 (56.7)Premorbid IQ103.03 ± 9.86107.85 ± 9.340.059Education (years)13.85 ± 2.0613.87 ± 3.810.982Number of hospitalization2.82 ± 3.30Duration of illness (years)13.57 ± 8.90Onset age (years)27.83 ± 9.83Dosage of antipsychotics (chlorpromazine equivalent, mg)495.06 ± 558.53Positive and negative syndrome scale Positive13.06 ± 6.57 Negative16.45 ± 6.19 General29.61 ± 8.30 Total59.12 ± 18.93TMT-A (seconds)31.28 ± 13.3528.38 ± 10.240.351TMT-B (seconds)107.47 ± 53.5584.97 ± 50.400.108Verbal fluency15.91 ± 4.8419.00 ± 5.820.027K-AVLT -- delayed recall6.31 ± 3.659.89 ± 2.08\< 0.001SFQ44.88 ± 11.9640.14 ± 7.770.066SOFAS63.73 ± 13.59[^1]

3.2. 40-Hz sensory activity at Cz {#s0065}
---------------------------------

There was no significant difference between the groups with regard to the mean baseline power (−3.33 ± 2.79 vs. −3.24 ± 2.42, *p* = .896). For total power, a significant group-by-time interaction revealed a greater total power in the later than in the earlier time blocks. Also, there were significant group differences (SZ \> HC) only in the time blocks after 200 ms (*ps* \< 0.01). For evoked power, a significant main effect of group showed a group difference (SZ \> HC) in the mean evoked power (0--500 ms) (*p* \< .05). In addition, a significant main effect of time showed greater evoked power in the later than in the earlier time blocks (*p* \< .001). However, there was no significant group-by-time interaction (*p* \> .05). For ITC, a significant main effect of group showed a group difference (SZ \> HC) in the mean ITC (0--500 ms) (*p* \< .05). In addition, a significant main effect of time showed greater ITC in the later than in the earlier time blocks (*p* \< .001). However, there was no significant group-by-time interaction (*p* \> .05). [Fig. 1](#f0005){ref-type="fig"} shows the grand average time-frequency maps and time course for total power, evoked power, and ITC at Cz in the 40-Hz frequency for the SZ and HC groups.Fig. 1The grand average of time-frequency maps and time course of total power, evoked power, and inter-trial phase coherence at Cz in the 40-Hz frequency for patients with SZ and HCs. Bars in the time course indicate the standard error. HC, healthy control; SZ, schizophrenia.Fig. 1

3.3. 40-Hz source activity {#s0070}
--------------------------

None of source activities in the STG showed a significant main effect of group or group-by-hemisphere interaction. For the baseline source activity of the STG, the main effect of hemisphere (left \> right) was significant (*p* \< .05). The main effect of group and the interaction term were not significant (*p* \> .05). For the total and evoked source activities of the STG, the main effects of hemisphere (left \> right) were significant (*ps* \< 0.05). The main effects of group and the interaction terms were not significant (*ps* \> 0.05).

3.4. MRI volume {#s0075}
---------------

In this study, there was no significant difference between the groups regarding TIV. For STG, there was a marginally significant main effect of group (*F* (1, 58) = 3.782, *p* = .057). However, there were neither a significant main effect of hemisphere (*F* (1, 58) = 2.584, *p* = .113) nor group-by-hemisphere interaction (*F* (1, 58) = 1.158, *p* = .286). A post-hoc analysis revealed that the volume of the STG (left and right averaged) was marginally smaller in patients with SZ compared to HCs (6.19 ± 0.95 vs. 6.55 ± 0.88, *p* = .057).

3.5. Regression analyses for ASSR measures at Cz and STG volume {#s0080}
---------------------------------------------------------------

Following the 5000 bootstrap resampling technique, there was only a finding for mean evoked power (0-500 ms) at Cz and the right STG, with simple effect analyses of a significant interaction term (R^2^ = 0.224, F = 2.459, df = 51, *p* = 0.036) showing an association between evoked power at Cz and right STG volume in HCs but not in patients with SZ (see [Fig. 2](#f0010){ref-type="fig"}), a pattern observed after considering TIV, medication dose, and duration of illness. However, associations were not observed for total power or ITC at Cz. Furthermore, no associations were observed between STG source activity and STG volume.Fig. 2The mean evoked power (0--500 ms) at Cz was significantly associated with right STG volume in HCs, while it was not significantly associated with right STG volume in patients with SZ. SZ: mean evoked power = − 1.602 \* right STG volume -- 0.002 \* TIV -- 0.002 \* CPZ equivalent +0.036 \* duration of illness +19.721 + error, HC: mean evoked power = 2.031 \* right STG volume -- 0.012 \* TIV + 9.196 + error. CPZ, chlorpromazine; HC, healthy control; STG, superior temporal gyrus; SZ, schizophrenia; TIV, total intracranial volume.Fig. 2

3.6. Regression analyses for psychological measures and ASSR measures at Cz {#s0085}
---------------------------------------------------------------------------

Following the 5000 bootstrap resampling technique, there was only a finding for verbal fluency and mean evoked power (0-500 ms) at Cz, with simple effect analyses of a significant interaction term (R^2^ = 0.223, F = 2.984, df = 52, *p* = 0.019) showing an association between verbal fluency and evoked power at Cz in patients with SZ but not in HCs (see [Fig. 3](#f0015){ref-type="fig"}), a pattern observed after considering medication dose and duration of illness. However, associations were not observed for total power or ITC at Cz. Furthermore, no associations were observed between psychological measures and STG source activity.Fig. 3Mean evoked power (0--500 ms) was significantly correlated with verbal fluency in patients with SZ, while it was not significantly associated with verbal fluency in HCs. SZ: verbal fluency = − 0.407 \* mean evoked power -- 0.001 \* CPZ equivalent -- 0.165 \* duration of illness +21.204 + error, HC: verbal fluency = 0.333 \* mean evoked power + 17.770 + error. CPZ, chlorpromazine; HC, healthy control; SZ, schizophrenia.Fig. 3

4. Discussion {#s0090}
=============

We examined group differences in the 40-Hz ASSR as well as associations between 40-Hz ASSR activity, brain structure, and cognitive ability in HC and patients with SZ. The SZ group showed a higher ITC and larger total power and evoked power than HCs at Cz. In addition, mean evoked power at Cz was significantly positively correlated with right STG volume in HCs but not in patients with SZ. The group differences in ASSR measures as well as the associations between ASSR measures and STG volume were only found in ASSR measures at Cz but not in STG source activity. Only a few studies have attempted ROI-based source localization of 40-Hz ASSR using EEG in SZ to date. One study showed no differences between patients with SZ and HCs on ASSR source activity but significant differences on ASSR sensor activity, results that are in line with the current results ([@bb0210]). However, another study found significant differences between patients with SZ and HCs for ASSR source activity ([@bb0275]). Few studies that conducted source analysis of 40-Hz ASSR using MEG in SZ, found a group difference in STG source activity ([@bb0410]) and a significant relationship between STG source activity and STG thickness ([@bb0060]). Methodological aspects such as spatial resolution and the registration of individual MRI might have contributed to the differences in the results between the current study and the previous ones.

4.1. ASSRs {#s0095}
----------

The current study found elevations in ITC and evoked power in SZ, whereas many of the previous studies have reported reductions in ITC and evoked power in SZ ([@bb0225]; [@bb0310]; [@bb0415]). While the reasons for this discrepancy are unclear, sample characteristics and different stimulus parameters might partly account for the current results. For example, while the present study included a relatively even percentage of male and female patients (female = 51.52%), many studies predominantly included male participants ([@bb0225]; [@bb0350]; [@bb0400]). Healthy female participants have been often found to exhibit higher oscillatory responses across several frequency ranges, including the gamma band ([@bb0110]; [@bb0170]). ASSR amplitudes and phase-locking measures may be influenced by female steroid hormones levels ([@bb0100]; [@bb0420]) and interact with handedness ([@bb0265]). Although our post-hoc analysis did not reveal statistically significant sex differences in the 40-Hz ASSR measures in either SZ or HC, the effect of sex and its interaction with handedness needs to be investigated in the future. In addition, some studies have suggested an age effect on the 40-Hz ASSR measures ([@bb0065]; [@bb0385]). However, our study did not show a statistically significant correlation between age and 40-Hz ASSR measures in either group.

Moreover, we applied a longer inter-train interval (3050--3500 ms) than most previous studies (\<1000 ms). Interestingly, Hamm et al. ([@bb0125]) employed a long ISI (\~3000 ms) and reported higher ITC and larger induced and evoked power in the SZ than the HC group. The difference in ISI might explain our result of no group difference in baseline power as well. Several previous studies have reported increased baseline power during the 40-Hz ASSR in patients with SZ compared to HCs ([@bb0150]; [@bb0345]), but Hamm et al. ([@bb0125]) and the current study did not confirm this finding. One possibility is that the relatively long ISI might make it more difficult to detect baseline power differences, since a longer ISI may better resemble the resting state as in the study of Hirano et al. ([@bb0150]), which found no group differences in the resting-state power.

To investigate the effect of the length of inter-train interval on the results of the 40-Hz ASSR measures, we applied an ASSR paradigm with a 500-ms inter-train interval to eight patients with SZ and nine HCs for exploratory purposes (supplementary material). The exploratory analyses were conducted on Fz, FCz, and Cz electrodes. For the short inter-train interval, patients with SZ showed significantly reduced ITC compared to HCs. In addition, patients with SZ showed higher baseline power and lower total and evoked powers. It is possible that a long ISI will contribute to generation of the gamma band response by modulating the refractory time of pyramidal cells and interneurons in SZ.

Increased stimulus-induced gamma (i.e., total power) in this study corroborated the results of several previous studies ([@bb0125]; [@bb0150]; [@bb0380]). Teale et al. ([@bb0380]) found increased stimulus-induced gamma power in patients with SZ. Hirano et al. ([@bb0150]) found that stimulus-induced gamma powers measured during the 40-Hz auditory steady state stimulation and task baseline were increased in patients with SZ compared with HCs. They suggested that enhanced gamma power in SZ may be a biomarker for the NMDAR dysfunction of fast-spiking inhibitory interneurons in neuropsychiatric disorders ([@bb0150]). Interestingly, the group difference was not observed during the 0--100 ms period, indicating that the 40-Hz ASSR anomaly in SZ may not be apparent at the very early stage of the ASSR. This is consistent with the results of several other studies that found no difference in the 40-Hz ASSR in early latency ([@bb0060]; [@bb0365]).

Increased gamma band ASSRs may be due to several factors including NMDAR dysfunction in SZ ([@bb0230]; [@bb0305]; [@bb0355]), gray matter abnormalities ([@bb0060]), GABA abnormalities ([@bb0400]), and the relatively old age of the participants in this study ([@bb0065]). Furthermore, ketamine, in both humans and animals, increases evoked and total gamma power ([@bb0305]; [@bb0405]). In a recent study, the 40-Hz ASSR was both inhibited and disinhibited in the rodent brain depending on the temporal dynamics and the dose of NMDA antagonist used ([@bb0340]). This suggests the importance of carefully considering the experimental methods and participant characteristics that may modulate the 40-Hz ASSR measures in healthy and neuropsychiatric populations ([@bb0160]). Given the small magnitude of ASSR measure effect sizes reported in a recent meta-analysis ([@bb0385]), the systematic investigation of modulating factors may lead ASSR measures to become a definite biomarker of SZ.

A growing number of studies have reported that the 40-Hz ASSR is a complex phenomenon possibly modulated by factors such as sex and ISI, as mentioned above, as well as attentional demand ([@bb0105]), antipsychotic medication status, and illness progression ([@bb0005]; [@bb0365]). Therefore, future study would benefit from considering these multiple factors.

4.2. ASSRs and STG volume {#s0100}
-------------------------

Right STG volume was significantly positively correlated with mean evoked power at Cz only in HCs. This result is in line with a recent finding that the 40-Hz total power and ITC were positively correlated with left STG cortical thickness only in HCs ([@bb0060]). Patients with SZ may have lost this association due to brain anatomical alterations, such as reduced pyramidal cell volume in the STG deep layer ([@bb0360]).

4.3. ASSRs and psychological measures {#s0105}
-------------------------------------

Patients with SZ had significantly lower scores in verbal fluency and verbal memory compared to HCs. Previous studies have shown that verbal fluency and verbal memory are the most impaired domains of cognitive function in SZ ([@bb0010]; [@bb0045]; [@bb0135]; [@bb0140]). However, there was no group difference in the attentional task, indicating that the patients in this study might have had rather preserved attentional functions. In addition, high mean evoked power at Cz significantly correlated with poor verbal fluency in SZ. Few studies have reported an association between the 40-Hz ASSR and cognitive function, including working memory ([@bb0250]) and attention ([@bb0365]). Other studies, however, reported a null relationship ([@bb0205]). Our finding supports the idea that gamma oscillatory deficits may be associated with cognitive dysfunction in SZ ([@bb0095]).

4.4. Limitations {#s0110}
----------------

First, most patients with SZ had chronic illness and were receiving atypical antipsychotics. A previous longitudinal study found that cortical thinning was associated with higher cumulative antipsychotic intake in patients with SZ ([@bb0395]). Although we controlled the dosage of medication, future studies are warranted to assess the duration of medication treatment and include drug-naive patients. Second, we examined the 40-Hz ASSR measures at Cz, which could be problematic as Cz measures combined left and right STG activity. Third, we included the entire STG as an ROI associated with the 40-Hz ASSR and did not constrain the analysis to the primary and secondary auditory cortices. Given the complexity of brain oscillations and the heterogeneity of the pathophysiology of SZ, wider brain areas may be included as ROIs, where relevant.

5. Conclusion {#s0115}
=============

Overall, this study demonstrated elevated gamma responses in SZ. The results were consistent with the NMDAR hypofunction model of SZ and supported other possibilities such as gray matter abnormalities and GABAergic dysfunction in SZ. Our finding suggested that the length of the ISI could be an important factor to consider with regard to the 40-Hz ASSR in SZ. Future studies, with sufficient statistical power, are needed to verify the observed tentative effect of the ISI length on the 40-Hz ASSR in patients with SZ and HCs. Furthermore, we found that right STG volume was related to the mean evoked power at Cz in the HC group, whereas patients with SZ did not show this association, possibly due to brain anatomical alterations. Finally, our results support the importance of gamma synchrony of the 40-Hz ASSR with cognition in SZ.
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[^1]: HC, healthy control; IQ, intelligence quotient; K-AVLT, Korean Auditory Verbal Learning Test; SFQ, Social Functioning Questionnaire; SOFAS, Social and Occupational Functioning Assessment Scale; SZ, schizophrenia; TMT-A, Trail Making Test-A; TMT-B, Trail Making Test-B.
